Extended Duration Pharmacotherapy for Prevention of Relapse to Smoking
Phase of Trial: Phase IV
Latest Information Update: 20 Nov 2017
At a glance
- Drugs Varenicline (Primary)
- Indications Schizoaffective disorder; Schizophrenia; Smoking withdrawal
- Focus Therapeutic Use
- Acronyms SCRP
- 01 May 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Jul 2008 Status changed from initiated to recruiting based on information from ClinicalTrials.gov.
- 12 Mar 2008 New trial record.